DEA Archived Press Releases

Press Releases before January 20, 2025
379 Results - Showing 121 to 130
PRESS RELEASE

Lowell Gang Member Pleads Guilty in Drug Trafficking and Money Laundering Conspiracies

BOSTON – A leader of a Lowell-based gang, One Family Clique (OFC), has pleaded guilty to conspiring with fellow OFC gang members to traffic wholesale quantities of cocaine, and to launder millions of dollars in drug proceeds through casinos in Canada. Virak Prum, a/k/a “Polo,” a/k/a “Capo,” a/k/a “Lips,” 36...
PRESS RELEASE

Five Men Charged With Using New York Diamond District Companies As Front To Illegally Move More Than $600 Million

NEWARK, NJ. – Five men who work in New York City’s Diamond District were arrested today and charged with illegally processing more than $600 million through unlicensed money transmitting businesses, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and U.S. Attorney Philip R...
PRESS RELEASE

Drug Ring Leader Sentenced to 21+ years in Prison

EAST ST. LOUIS, Ill. – A U.S. District judge sentenced a California man to 21 year and 10 months in prison after he admitted to leading a drug conspiracy ring targeting communities in southern Illinois. Thomas Hines, 33, of Los Angeles, pled guilty to one count of conspiracy to distribute...
PRESS RELEASE

Health Care Company and Cheshire Pharmacy Pay $500K to Resolve Controlled Substances Act Allegations

CHESHIRE, Conn. - Vanessa Roberts Avery, United States Attorney for the District of Connecticut, Brian D. Boyle, Special Agent in Charge of the Drug Enforcement Administration for New England, announced that Clarest, LLC, doing business as Clarest Health, ProCare LTC New England LTC, and ProCare LTC Pharmacy of Connecticut LLC...
PRESS RELEASE

Former Auburn Physician Pays $135,000 and Forfeits DEA Registration, for Overprescribing Controlled Substances

SYRACUSE, NEW YORK – Dr. Jang Boo Chi, formerly a physician in Auburn, and his medical practice, Jang Boo Chi M.D. P.C., have agreed to pay the United States $135,000 in civil penalties for overprescribing opioids and other controlled substances in dangerous combinations. United States Attorney Carla B. Freedman, and...
PRESS RELEASE

Austin Pharmacy to Pay $200,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act

AUSTIN, Texas – People’s Pharmacy Inc. has agreed to pay $200,000 in civil penalties to resolve allegations that it violated provisions of the Controlled Substances Act (CSA). People’s Pharmacy Inc., doing business as Peoples Rx, operates five retail pharmacies and one compounding laboratory in the Austin area. During a routine...
PRESS RELEASE

CA Attorney General Bonta Announces Arrest of Santa Clara Doctor for Illegal Opioid Prescription Scheme

SANTA CLARA, Calif. — California Attorney General Rob Bonta today announced the arrest of and filing of charges against Dr. Arash Padidar, a Santa Clara County doctor accused of illegally prescribing opioids to patients. The arrest and charges are the result of an investigation into an alleged two-years-long illegal prescription...
PRESS RELEASE

Nurse Practitioner Pleads Guilty to Unlawful Drug Distribution

ALBANY, NEW YORK – Danielle Simonson, age 51, of Fort Ann, New York, pled guilty today to distributing controlled substances outside the course of professional practice and for no legitimate medical purpose. The announcement was made by United States Attorney Carla B. Freedman; Special Agent in Charge Frank A. Tarentino...
PRESS RELEASE

Multiple People Indicted for Meth Trafficking, Money Laundering

KANSAS CITY, KAN. – A federal grand jury in Kansas City returned an indictment charging multiple people for their alleged involvement in a conspiracy to distribute methamphetamine within the state of Kansas and elsewhere between February 2020 and July 2023. According to court documents, Jose Roman, 43, Marcos Valencia Jr...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...